Skip to content
healthcare.dev

Oxaliplatin

NDC 61703-363, OXALIPLATIN, injection, solution, concentrate, from Hospira, Inc..

Product NDC
61703-363
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078813
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61703-363 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXALIPLATIN5 mg/mL

Pharmacologic classes

Platinum-based Drug [EPC]; Platinum-containing Compounds [EXT]

Package NDCNDC-11Package
61703-363-18617030363181 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-18) / 10 mL in 1 VIAL, SINGLE-DOSE
61703-363-22617030363221 VIAL, SINGLE-DOSE in 1 CARTON (61703-363-22) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e51a62ba-d163-4c57-835c-8c86cf097e40
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61703-363

Use it

Look up 61703-363 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61703-363 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61703-363. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.